chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The next day after my vaccination shot I experienced excruciating pain in both of my breast, chest and underarm. I had to call the ambulance because it was unbearable - I was having difficulty breathing and when the ambulance came to my house they drove me to the ER. When I got to the ER they did X-Ray, Blood work, EKG. My blood pressure was really high 167/100. I followed up with my doctor right after and he said it was an adverse reaction to my Pfizer Covid 19 vaccine. I was advised to apply ice all over my body pain and take Tylenol - -no prescribed medicines were given. My symptoms took 1 week and half before it subsided.
3/24/2021--4pm began feeling weak 3/24/2021--6pm severe dizziness and close to passing out; weak, hands and thighs began to tingle 3/24/2021--6:30pm severe dizziness; started to black out again; extremely cold, weak, hands numb, began shaking uncontrollably 3/24/2021--7:00pm above symptoms continued, vitals taken at home:  pulse normal, 100/60 bp (normal for me), temp 98.4 (high for me) 3/24/2021--8:00pm  above symptoms continued except hands no longer numb and not shaking; temp 100.4 (very high for me) 3/24/2021--9:00pm above symptoms continued and bad headache began 3/25/2021--1:00am  cold, weak and raging headache 3/25/2021--4:45am  same and extreme thirst 3/25/2021--above continued all day 3/25/2021--8:00pm  less cold, headache became more mild 3/26/2021--7:00am  mild headache, extreme thirst, mild weakness (but ok enough to do light workout) 3/26/2021--12:00pm extreme thirst continued all day 3/27/2021--back to normal
9:15 pt recv vax & stood up & fainted;pt fell back into chair;fainting lasted for few seconds;pt pale, c/o nausea;amb called 9:20, BP 90/40, pulse 48, resp 24, pt vomited;amb arrived 9:25 & transported pt to hosp ER;
I have short term memory loss and gastrointestinal issues. I also have extreme back pain.
Less than 1 month after receiving vaccine, I experienced weakness and shortness of breath. Went to ER. Was hospitalized with multiple pulmonary embolisms in right lung. I am now on blood thinner Eliquis, and oxygen therapy which may be permanent
She experienced soreness at the injection site but has continued to have pain for the last month in her arm.  SHE COMPLAINS OF MUSCLE SORENESS BUT ALSO PAIN GOING DOWN INTO HER HAND. SHE STATED SHE CAN'T USE HER ARM, HAS PAIN WHENEVER SHE TRIES TO LIFT IT. SHE HAS NOT BEEN EVALUATED BY A DR. I RECOMMENDED HER TO GO get evaluated by a physician.
Pain in shoulder a few hours after shot and then dizziness and fainting approximately 18 hours after vaccine that resulted in injury.
15-month-old male patient had inadvertently received an expired dose of Daptacel, with no reported AE; Initial information received on 20-Aug-2021 regarding an unsolicited valid non-serious case from a nurse via Medical Information (Reference number- 00733906).  This case involves a 15 month old male patient who was inadvertently vaccinated with the expired dose of suspect DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [DAPTACEL] (expired product administered).  Medical history, medical treatment, vaccination and family history were not provided.  Concomitant medications included HIB VACCINE CONJ (TET TOX) (ACT-HIB) and PNEUMOCOCCAL VACCINE CONJ 7V (CRM197) (PREVNAR) for Prophylactic vaccination.  On 19-Aug-2021, the patient received a 0.5 ml dose of suspect DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE (lot C5624AA and expiry date: 10-Jun-2021) (Strength: Standard, Frequency: once) via an unknown route in the left thigh for prophylactic vaccination.  It was an actual medication error case due to expired vaccine used (latency on same day).  At time of reporting, no adverse event was reported.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Patient reported that she had episode of confusion on April 21 ( friday) evening - 3 days after she had vaccines. pt reported she had slurred speech, did not remember what was going and lost tract of time for few days. she state she felt back to normal on 4/26/2023. Felt exhausted and slept on and off.  no other associated symptoms
got covid Virus; got covid Virus; This is a spontaneous report from a Pfizer-sponsored program . A contactable consumer (patient) reported similar events for 02 patient. This is the 2nd of 02 reports. This consumer reported for a male patient (husband). A male patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiration date not reported) via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The patient medical history and concomitant medications was not reported. The patient experienced got COVID virus after receiving the 1st dose of vaccine. The outcome of the events was reported as unknown.  Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021223614 same drug and event, different patient
Slight headache for several days.  Feeling of ice water in random veins. First day was up left side of head, then in chest and last place several days later was in backbone.  Each time feeling was only for a few minutes.  Slight fever for 3 days.  No other symptoms.
Severe muscle aches in neck, back, arms, and legs. Severe light sensitive headache.
Patient was discharged from the hospital after massive PE. She went to the hospital at 2am last Saturday. Patient described unbelievable pain from shoulder neck and arms. She could hardly walk to her car. Went to ER. There they ran tests and found many blood clots in lungs. Blood clots had stopped the blood in that area. They were not definitive but said it sounded like that. Got a breathing apparatus after because it's been hard to breathe and she has been shaky.  Her shot was administered 04/12 during chemo. Hospital April 24. She was discharged and given a blood thinner and pain medication - Oxycodone & Eliquis.
Cellulitis; Swelling in 2/3 of her arm; Arm was hot; Arm was tender; Patient's arm developed several indurations that were overlapping circles of 3 to 6 cm in size; This case was reported by a nurse via call center representative and described the occurrence of cellulitis in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced cellulitis (serious criteria GSK medically significant), swelling arm, extremities hot feeling of, pain in arm and induration. The patient was treated with antibiotics nos. On an unknown date, the outcome of the cellulitis, swelling arm, extremities hot feeling of, pain in arm and induration were unknown.   It was unknown if the reporter considered the cellulitis, swelling arm, extremities hot feeling of, pain in arm and induration to be related to Shingrix.  Additional case details were provided as follows: This case was reported by the family nurse practitioner. The age at vaccination was not reported. The patient experienced swelling in 2/3 of her arm, which was also hot and tender, after the Shingrix vaccination.  The patient's arm developed several indurations that were overlapping circles of 3 to 6 cm in size. The patient went to the emergency room, was diagnosed with cellulitis, and given antibiotics. The reporter consented to follow up.
This spontaneous report was received from a nurse refers to unspecified patients of unknown age. The patients' medical history, concomitant medication and concurrent conditions were not reported. Since 09-MAR-2017, the patients had been vaccinated with improperly stored doses of GARDASIL 9, from lot # M034780, expiry: 15-APR-2019 and lot# M042853, expiry: 17-JUL-2019, for prophylaxis. No adverse effect reported. The vaccine was exposed to -4.4 degree Celsius for 1,057 hours (44 days) and 9 degree Celsius to 25 degree Celsius for 2 hours. The call was due to data logger. This is one of four reports received from the same reporter. Sender's Comments: US-009507513-1708USA007863: US-009507513-1708USA007864: US-009507513-1708USA007865.
Woke up with a very sore throat - raw from blisters on it -   about 10 days after. I didn't have a fever. I tested negative for strep - based on how my throat looked they treated it for strep. They gave me antibiotics and it took me the whole round to get over it. So it lasted about ten days.
on the 2nd felt very tired had lots of rest; I even feel more energetic; This is a spontaneous report received from a non-contactable reporter (Consumer) for a sponsored program. The reporter is the patient.  A female patient received BNT162B2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.Vaccination history included: BNT162B2 (Dose 1, Single, (Lot # not provided)), for COVID-19 immunization, reaction(s): "Headache", "Minor sore on the short area". The following information was reported: FATIGUE (non-serious) with onset Apr2021, outcome "recovered", described as "on the 2nd felt very tired had lots of rest"; ENERGY INCREASED (non-serious) with onset Apr2021, outcome "unknown", described as "I even feel more energetic".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021492901 same patient and drug; different event and dose
pain at the injection site; had redness at the injection site; swelling and pain at the injection site; affected mobility of his right arm; This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in a male patient who received Herpes zoster (Shingrix) (batch number ZX27E, expiry date 16th September 2022) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced injection site pain, injection site erythema, injection site swelling and injected limb mobility decreased. On an unknown date, the outcome of the injection site pain, injection site erythema and injection site swelling were unknown and the outcome of the injected limb mobility decreased was not recovered/not resolved.   It was unknown if the reporter considered the injection site pain, injection site erythema, injection site swelling and injected limb mobility decreased to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix and had redness and swelling and pain at the injection site.  It has affected mobility of his right arm. The HCP stated that he reported the AE to VAERS but gave me lot and expiration date and gender of patient.
patient received Adacel Vaccine that had been frozen and thawed; Initial information received on 07-Aug-2019 regarding an unsolicited valid non-serious case received from consumer/non-health care professional.  This case is linked to cases 2019SA224138, 2019SA224143, 2019SA224144, 2019SA224139, 2019SA224140, 2019SA224141, 2019SA224076, 2019SA224136, 2019SA224137 and 2019SA224145 same reporter.  This case involves patient of an unknown demographics who received 0.5 mL dose of vaccine DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL] (Lot- C55608AA, expiry date-25-01-21 or Lot- C5585AA, expiry date-10-03-21) via intramuscular route in unknown administration site (received between the date 26-Mar-2019 - 24-Jun-2019) which had been frozen and thawed.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was a case of actual medication error due to Product storage error temperature too low.  There were no side effects.  Caller stares that her facility was using the Adacel vaccine and she was going through the fridge log and realized that she was not being informed when the vaccines were out of the 2 to 8 Celsius range. Caller states that there are 2 situations. Caller states that she looked at July and the vaccines dropped to 1.4 C and 1.5 C. Caller states she consulted with a scientist and was told that their thermometer was not the appropriate one for the vaccines and that it was only monitoring the air temperature and not the vaccines. Caller states that the same vaccines have gotten down to -4 C a month before this current excursion occurred. Caller states that a new thermometer with fluid was ordered so that the readings can be more accurate now. Caller would like to know what are the next steps that she needs to take in ensuring that her patients are properly vaccinated.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.
Red, 8" x 2" area covering upper arm. Warm to touch. Gave Benadryl and sent to ER for further evaluation.
he received only one dose of shingrix 3 years ago; This non-serious case was reported by a physician via call center representative and described the occurrence of incomplete course of vaccination in a 73-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (3 years ago from reporting, received 1st dose).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: he received only one dose of shingrix 3 years ago). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt date: 07-JUN-2023 A physician reported this case for himself. The reporter consented to follow up. Till the time of reporting, the patient did not receive the second dose of Shingrix, which led to incomplete course of vaccination.
patient received a yellow fever vaccine intramuscularly instead of the recommended route of administration which is subcutaneously with no reported adverse event; Initial information was received on 21-Apr-2023 regarding an unsolicited valid non-serious case received from an other health professional.  This case involves an unknown age/gender patient who received a yellow fever vaccine [YF-vax] intramuscularly instead of the recommended route of administration which is subcutaneously with no reported adverse event.   The patient's past medical history, medical treatment(s), concomitant medications, vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect yellow fever vaccine Solution for injection (dose, strength, lot number, batch number, expiration date and administration site: Unknown) via intramuscular route instead of the recommended route of administration which is subcutaneously with no reported adverse event (incorrect route of product administration) (latency: same day)  No lab data reported.  Action taken: not applicable.  Outcome: Unknown for the event patient received a yellow fever vaccine intramuscularly instead of the recommended route of administration which is subcutaneously with no reported adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Patient called stated adult PCV13 was given on 11-23-15, warm to touch, black spot at injection site, slightly painful.
This case was reported by a other health professional via call center representative and described the occurrence of joint range of motion decreased in a patient who received FLUARIX QUADRIVALENT 2018-2019 season (batch number Y279A, expiry date 30th June 2019) and (batch number 92XR5, expiry date 30th June 2019) for prophylaxis. On an unknown date, the patient received FLUARIX QUADRIVALENT 2018-2019 season. On an unknown date, the dose was an unknown dose. On an unknown date, less than a year after receiving FLUARIX QUADRIVALENT 2018-2019 season, the patient experienced joint range of motion decreased. On an unknown date, the outcome of the joint range of motion decreased was unknown. It was unknown if the reporter considered the joint range of motion decreased to be related to FLUARIX QUADRIVALENT 2018-2019 season. Additional details were received as follows: The age at vaccination was not reported. The physician reported that they had 8 patients who experienced limited range of motion in their arm after receiving the FLUARIX vaccine. The could not identify the patients who received the FLUARIX. They stated that 8 patients out of 1400 patients developed limited range of motion after receiving the FLUARIX vaccine. The reporter did not have specific patient information. The reporter stated that the patients required follow up treatment.  The healthcare professional (HCP) did not give specifics on what that treatment involved. The reporter consented to follow up. This is 1 of 8 cases reported by the same reporter. There are 2 batch numbers provided for FLUARIX QUADRIVALENT 2018-2019 season, but it is not sure which is the correct batch number.
112/72 BP, 91 Pulse, 96% O2 sat. Pt c/o diaphoretic. No other c/o, no rash, SOB, hives, scratchy throat. Pt experienced with the 1st vaccine. Pt was evaluated & released to self. Pt had no other sxs after going home. 1520 VS 120/80. 85, 97% pt's skins are W/D. Pt drank some water. Pt feels back to normal. Pt will drive herself home. No dizziness, no other c/o. Pt doesn?t need any other medical attention. She is aware to call 911 if necessary should anything else occur while driving home.
fainted - it was very brief; sweating a lot after fainting; felt her legs were very weak; chills \ shivers; fever; This spontaneous case was reported by a patient and describes the occurrence of SYNCOPE (fainted - it was very brief), HYPERHIDROSIS (sweating a lot after fainting), MUSCULAR WEAKNESS (felt her legs were very weak), CHILLS (chills \ shivers) and PYREXIA (fever) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-May-2021, the patient experienced CHILLS (chills \ shivers) and PYREXIA (fever). On 07-May-2021, the patient experienced SYNCOPE (fainted - it was very brief), HYPERHIDROSIS (sweating a lot after fainting) and MUSCULAR WEAKNESS (felt her legs were very weak). On 06-May-2021, CHILLS (chills \ shivers) and PYREXIA (fever) had resolved. On 07-May-2021, SYNCOPE (fainted - it was very brief) and MUSCULAR WEAKNESS (felt her legs were very weak) had resolved. At the time of the report, HYPERHIDROSIS (sweating a lot after fainting) outcome was unknown.            Action taken with mRNA-1273 in response to events was not applicable  No concomitant medications were reported.   No treatment information was provided.  Based on the current available information and temporal association between the use of the product and the start date of the events syncope, hyperhidrosis, muscle weakness, chills and pyrexia, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events syncope, hyperhidrosis, muscle weakness, chills and pyrexia, a causal relationship cannot be excluded
Pain and soreness at injection site x48 hours, onset 3 hours after injection Fatigue, aches, chills, fever x36 hours, onset 3 hours after injection Bruising and itching to legs x4 days, onset 12 hours after injection, ongoing
Dizziness, loss of voice, swollen tongue & back of throat, difficulty swallowing, extreme headache, &  extreme neck ache. EMT's on site gave me a shot of 50 mg of Benadryl in my right arm.  Halted the symptoms from getting worse, but symptoms did not clear until 24-48 hrs later.
Mom reports & emailed picture of swelling in her arm s/p (re same night) of her imm.
recently got the booster vaccine and he's experiencing some side effects; his in pain; bump in the armpit; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION COMPLICATION (recently got the booster vaccine and he's experiencing some side effects), PAIN (his in pain) and LYMPHADENOPATHY (bump in the armpit) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2022, the patient experienced VACCINATION COMPLICATION (recently got the booster vaccine and he's experiencing some side effects), PAIN (his in pain) and LYMPHADENOPATHY (bump in the armpit). At the time of the report, VACCINATION COMPLICATION (recently got the booster vaccine and he's experiencing some side effects), PAIN (his in pain) and LYMPHADENOPATHY (bump in the armpit) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This was reported for reporters dad who recently got the booster vaccine. No concomitant medication details was provided. No treatment medication details was provided.
Tingly tongue and dry mouth; states had it with last vaccine. dizzy and nausea after getting to the Emergency Department
Heart palpitations  severe headache  shortness of breath  lasted about 15 minutes after I left the site once I stood up. Had headache and shortness of breath and dizziness for 2 days after but not as severe  took aleve drunk lots of floods and rested for 3 days
Patient started experiencing normal arm pain for a few days after vaccine, however pain is still ongoing since 10/8, almost 2 months later. The pain decreased, now it is just when she is lifting her arm, she feels a sharp pain.
Initial report received from a health care professional on 24 Jun 2010: This patient was inadvertently vaccinated with only the liquid conjugate of MENVEO (batch number: 100003), (dose: unknown) intramuscularly on an unspecified date. No adverse reaction had occurred following this administration. Follow up report received from physician on 20 Jul 2010: The patient's demographics was provided. The patient didn't had any adverse event, the patient was inadvertently vaccinated with only the liquid conjugate of MENVEO vaccine on 15 Jun 2010: The patient was taking ZYRTEC (10 mg, daily), and SINGULAIR (5 mg, daily). from an unknown date, for allergic reaction. No further information was provided.
Broke out in hives, urticaria (4 hours post injection of PREVNAR 13). Urgent care tx 3/19/16 eval w/PCP on 3/23/16 for continuing symptoms.